Dr. Vince is chief of Cleveland Clinic Innovations and chair of biomedical engineering at Cleveland Clinic, where he has led enterprise commercialization strategy since 2021. In 2024, Cleveland Clinic Innovations issued 144 patents, secured 53 new licensing deals and supported 263 invention disclosures, representing year-over-year increases across each metric. He strengthened the organization’s invention-to-license conversion rate, increasing it from 19% in 2021 to 26% in 2024 through more strategic support for inventors and tighter alignment to market needs. Under his leadership, the portfolio has diversified beyond its historically device-heavy focus to include 27% digital health and 23% therapeutics and diagnostics. Dr. Vince also expanded the organization’s global innovation footprint by integrating efforts across Cleveland Clinic London and Cleveland Clinic Canada while advancing scaling pathways connected to Cleveland Clinic Abu Dhabi. Cleveland Clinic has launched over 100 startups.
